Transforming growth factor-β1 enhances the antifibrinolytic and prothrombotic state of growing endothelial cells in a cell cycle-specific manner

FASEB Journal

Volumn 20, Issue 7, 2006, Pages

  Stoldt, Volker R ^a   Schnorr, Oliver ^a   Schulze Osthoff, Klaus ^a   Scharf, Rudiger E ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Angiogenesis; Homeostasis; Human umbilical vein endothelial cells; Plasminogen activator inhibitor; Tissue repair

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

CELL CYCLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR;

EID: 33845659017     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-3032fje     Document Type: Article

References (27)

1. Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B., et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561
2. Wu, K. K., and Thiagarajan, P. (1996) Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 47, 315-331
3. Assoian, R. K., and Sporn, M. B. (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102, 1217-1223
4. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., and Kehrl, J. H. (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83, 4167-4171
5. Heimark, R. L., Twardzik, D. R., and Schwartz, S. M. (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233, 1078-1080
6. Massague, J., Blain, S. W., and Lo, R. S. (2000) TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309
7. Massague, J. (2000) How cells read TGF-beta signals. Nat Rev Mol. Cell. Biol. 1, 169-178
8. Shi, Y., and Massague, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 13, 685-700
9. Massague, J., and Wotton, D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19, 1745-1754
10. Dennler, S., Itoh, S., Vivien, D., ten-Dijke, P., Huet. S., and Gauthier, J. M. (1998) Direct binding of Smad3 and Smad 4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3000
11. Song, C. Z., Siok, T. E., and Gelehrter, T. D. (1998) Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem. 273, 29,287-29,290
12. Gimborne, M. A. (1976) Culture of vascular endothelial. Prog. Hemost. Thromb. 3, 1-29
13. Pepper, M. S., Montesano, R., Orci, L., and Vassalli, J. D. (1991) Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta. Biochem. Biophys. Res. Commun. 176, 633-638
14. Ohji, T., Urano, H., Shirahata, A., Yamagishi, M., Higashi, K., Gotoh, S., and Karasaki, Y. (1995) Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb. Haemost. 73, 812-818
15. Tietze, L., Elbrecht, A., Schauerte, C., Klosterhalfen, B., Amo-Takyi, B., Gehlen, J., Winkeltau, G., Mittermayer, C., and Handt, S. (1998) Modulation of prothrombotic and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin (IL) 1beta (IL-1beta). Thromb. Haemost. 79, 362-370
16. Boehm, J. R., Kutz, S. M., Sage, E. H., Staiano-Coico, L., and Higgins, P. J. (1999) Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. J. Cell. Physiol. 181, 96-106
17. Hou, B., Eren, M., Painter, C. A., Covington, J. W., Dixon, J. D., Schoenhard, J. A., and Vaughan, D. E. (2004) Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site J. Biol. Chem. 279, 18,127-18,136
18. Le Breton, M., Cormier, P., Bellé, R., Mulner-Lorillon, O., and Morales, J. (2005) Translational control during mitosis. Biochimie (Paris) 87, 805-811
19. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J., and Loskutoff, D. J. (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 266, 23,048-23,052
20. Staiano-Coico, L., Carano, K., Allan, V. M., Steiner, M. G., Pagan-Charry, I., Bailey, B. B., Babaar, P., Rigas, B., and Higgins, P. J. (1996) PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding. Exp. Cell Res. 227, 123-134
21. Schleef, R. R., Higgins, D. L., Pillemer, E., and Levitt, L. J. (1989) Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest. 83, 1747-1752
22. Fay, W. P., Parker, A. C., Condrey, L. R., and Shapiro, A. D. (1997) Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene. Blood 90, 204-208
23. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., Nuffelen, A., Prendergrast, G., Cole, M., Bronson, R., Collen, D., and Mulligan, R. (1993) Plasminogen activator inhibitor-1 gene deficient mice. I. Generation of by homologous recombination and characterization. J. Clin. Invest. 92, 2746-2755
24. Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C., and Collen, D. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92, 2756-2760
25. Erickson, L. A., Fici, G. J., Lund, J. E., Boyle, T. P., Polites, H. G., and Marotti, K. R. (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 346, 74-76
26. Grainger, D. J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P. R., Metcalfe, J. C., Carter, N. D., and Spector, T. D. (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8, 93-97
27. Clouthier, D. E., Comerford, S. A., and Hammer, R. E. (1997) Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy like syndrome in PEPCK-TGF-beta1 transgenic mice. J. Clin. Invest. 100, 2697-2713